Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 17 studies | 36% ± 17% | |
| peripheral blood | 17 studies | 40% ± 14% | |
| intestine | 9 studies | 27% ± 11% | |
| kidney | 7 studies | 28% ± 6% | |
| brain | 6 studies | 27% ± 8% | |
| eye | 5 studies | 27% ± 12% | |
| uterus | 5 studies | 39% ± 13% | |
| lymph node | 5 studies | 26% ± 7% | |
| liver | 5 studies | 35% ± 16% | |
| pancreas | 4 studies | 46% ± 13% | |
| placenta | 4 studies | 27% ± 7% | |
| bone marrow | 4 studies | 33% ± 9% | |
| prostate | 4 studies | 37% ± 9% | |
| breast | 4 studies | 39% ± 8% | |
| thymus | 3 studies | 42% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 6749.70 | 459 / 459 | 100% | 81.75 | 1118 / 1118 |
| esophagus | 100% | 6477.56 | 1445 / 1445 | 100% | 53.80 | 183 / 183 |
| lung | 100% | 5384.44 | 578 / 578 | 100% | 57.99 | 1155 / 1155 |
| prostate | 100% | 5073.61 | 245 / 245 | 100% | 49.15 | 501 / 502 |
| ovary | 100% | 3997.38 | 180 / 180 | 99% | 33.11 | 427 / 430 |
| uterus | 100% | 3723.46 | 170 / 170 | 99% | 47.09 | 454 / 459 |
| thymus | 100% | 4014.65 | 652 / 653 | 99% | 32.81 | 599 / 605 |
| brain | 99% | 2932.79 | 2609 / 2642 | 100% | 46.32 | 705 / 705 |
| bladder | 100% | 4749.52 | 21 / 21 | 99% | 42.31 | 497 / 504 |
| liver | 100% | 5014.92 | 226 / 226 | 99% | 30.85 | 400 / 406 |
| intestine | 100% | 3929.51 | 966 / 966 | 98% | 44.78 | 515 / 527 |
| stomach | 100% | 3344.60 | 358 / 359 | 98% | 41.23 | 280 / 286 |
| adrenal gland | 100% | 6825.14 | 258 / 258 | 96% | 27.57 | 221 / 230 |
| kidney | 100% | 4042.94 | 89 / 89 | 96% | 31.19 | 861 / 901 |
| skin | 100% | 6834.67 | 1805 / 1809 | 94% | 38.47 | 445 / 472 |
| pancreas | 92% | 1757.19 | 301 / 328 | 98% | 42.96 | 175 / 178 |
| adipose | 100% | 7748.34 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 34.68 | 29 / 29 |
| spleen | 100% | 3246.20 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 41.57 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 20.51 | 1 / 1 |
| blood vessel | 100% | 5564.03 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 97% | 4520.26 | 782 / 803 | 0% | 0 | 0 / 0 |
| heart | 94% | 2936.26 | 808 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 90% | 3873.06 | 833 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 66% | 12.64 | 53 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006446 | Biological process | regulation of translational initiation |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | BZW1 |
| Protein name | eIF5-mimic protein 2 (Basic leucine zipper and W2 domain-containing protein 1) (Protein Orf) Basic leucine zipper and W2 domains 1 |
| Synonyms | KIAA0005 5MP2 BZAP45 |
| Description | FUNCTION: Translation initiation regulator which represses repeat-associated non-AUG (RAN) initiated translation probably by acting as a competitive inhibitor of eukaryotic translation initiation factor 5 (EIF5) function . Enhances histone H4 gene transcription but does not seem to bind DNA directly . . |
| Accessions | ENST00000409600.6 [Q7L1Q6-1] ENST00000452790.6 [Q7L1Q6-3] ENST00000450637.5 C9JWF5 ENST00000359893.4 C9JV57 C9J188 H0Y503 ENST00000410110.6 C9JFN4 Q7L1Q6 ENST00000452206.5 ENST00000419090.1 ENST00000409226.5 [Q7L1Q6-4] ENST00000447069.5 C9IZ80 |